Category Archives: Healthcare

JonesTrading Keeps Their Buy Rating on Celyad (CYAD)

In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Celyad (CYAD – Research Report), with a price target of $60.00. The company’s shares closed last Monday at $8.88, close to its 52-week low of $8.10.

TerrAscend Corp (TER) Receives a Buy from Clarus

The Healthcare company, TerrAscend Corp (TER – Research Report), has received a rating update from a Wall Street analyst today. The Healthcare company, TerrAscend Corp (CNQX: TER) has just received a rating update from a Wall Street analyst. According to

Cowen & Co. Maintains Their Buy Rating on Ovid Therapeutics (OVID)

In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Ovid Therapeutics (OVID – Research Report). The company’s shares closed last Monday at $2.55. According to TipRanks.com, Baral is a 5-star analyst with an

H.C. Wainwright Remains a Buy on Neon Therapeutics (NTGN)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Neon Therapeutics (NTGN – Research Report), with a price target of $12.00. The company’s shares closed last Monday at $2.00, close to its 52-week low

Stemline Therapeutics (STML) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Stemline Therapeutics (STML – Research Report) today and set a price target of $35.00. The company’s shares closed last Monday at $9.25, close to its 52-week low of $7.82. According

IntelGenx Technologies (IGXT) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on IntelGenx Technologies (IGXT – Research Report) today and set a price target of $1.00. The company’s shares closed last Monday at $0.62. According to TipRanks.com, Ramakanth has currently no stars